The juli Studies

The 2021 juli study for asthma and depression

juli has completed two research studies conducted by University College London. Over 500 patients with depression or asthma used juli for 8 weeks in two separate randomized controlled trials, where juli users were compared to participants using an active control. Both studies achieved their primary endpoint of statistically significantly superior improvements in PHQ-8 and ACT scores after 8 weeks. Remission/control was achieved in over 50% of depression patients and over 40% of asthma patients in these studies. The preprint of the results can be downloaded here:

There will be more juli studies. If you are interested in becoming a participant, sign up below for our newsletter.